+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Analytical Testing Outsourcing Market - Global Forecast 2026-2032- Product Image
Pharmaceutical Analytical Testing Outsourcing Market - Global Forecast 2026-2032- Product Image
New

Pharmaceutical Analytical Testing Outsourcing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 199 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5454989
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pharmaceutical analytical testing outsourcing market is undergoing a pivotal transformation, with leading firms using outsourced partnerships to address complex regulatory, technical, and operational demands. Strategic outsourcing is now essential not only for cost management but also for accelerating innovation, ensuring compliance, and enhancing overall market performance.

Market Snapshot: Pharmaceutical Analytical Testing Outsourcing

The pharmaceutical analytical testing outsourcing market expanded from USD 10.90 billion in 2025 to USD 11.82 billion in 2026, representing a compound annual growth rate (CAGR) of 9.89%. With this trajectory, projections estimate the market could reach USD 21.12 billion by 2032. Drivers behind this growth include the rising complexity of molecule modalities, stricter compliance requirements, and significant advances in technology. These forces are compelling sponsors to engage with partners capable of supporting sophisticated analytical workflows and scalable operations across global supply chains.

Scope & Segmentation

The scope of pharmaceutical analytical testing outsourcing encompasses a broad array of service types, technologies, molecule classes, applications, end users, regions, and project durations. Each segment brings distinct regulatory, technical, and operational implications for stakeholders across the value chain.

  • Service Types: Bioanalytical testing, impurity testing, microbiological testing, and stability testing address specific stages of drug development, with unique validation, documentation, and compliance needs shaping engagement models.
  • Technology Platforms: Chromatography methods such as GC, HPLC, and UHPLC are widely adopted for separating complex mixtures, while advanced mass spectrometry platforms including GC-MS, LC-MS/MS, and MALDI-TOF enable precise characterization. Spectroscopy techniques such as FTIR, NMR, and UV-Vis offer complementary modes of analysis. Cell-based assays increasingly feature in functional assessments for biologics and biosimilars.
  • Molecule Classes: Biologics require specialized handling, robust stability studies, and method development tailored to protein structure. Small-molecule drugs benefit from rapid, high-throughput screening and standardized quality assurance procedures.
  • Application Areas: Services extend across biosimilarity assessments, drug discovery and development, and ongoing quality control, each with distinct analytical standards, statistical documentation, and reporting expectations.
  • End Users: Academic and government institutions, biotechnology firms, contract research organizations, and pharmaceutical companies each prioritize different deliverables, compliance levels, and turnaround times in sourcing strategies.
  • Regions: Market participation spans the Americas, where speed-to-market and proximity are critical; Europe, Middle East, and Africa, which focus on regulatory harmonization; and Asia-Pacific, an increasingly competitive region for technical capacity and quality systems. Regional nuances influence service models and supplier qualification protocols.
  • Project Durations: Both short-term studies and long-term collaborations are prevalent, each affecting resource allocation, contract structuring, and the rigor of analytical method validation and transfer.

Key Takeaways: Strategic Evolution in Analytical Testing Outsourcing

  • Analytical testing outsourcing has evolved into a cornerstone of pharmaceutical strategy, shaping development timelines, regulatory submission readiness, and commercialization success.
  • Providers are broadening services through integration of advanced instrumentation, regulatory expertise, and workflow automation to address increasingly complex analytical requirements.
  • The market is witnessing consolidation, with strategic alliances enabling seamless end-to-end services and heightened focus on data governance and digital interoperability.
  • Procurement decisions weigh flexibility, depth of analysis, and the validation pedigree of technology stacks, allowing sponsors to respond rapidly to evolving needs while preserving compliance.
  • Internal quality teams are placing greater emphasis on detailed technology validation and scalability during vendor assessments, supplementing traditional criteria such as pricing and delivery timelines.
  • Building resilient sourcing strategies, transparent supplier qualification, and strong technical capabilities underpins long-term partnerships and helps mitigate operational disruptions.

Tariff Impact: Operational Recalibration and Supplier Diversification

Following tariff introduction in 2025, pharmaceutical analytical testing outsourcing underwent substantial adaptation. Procurement teams diversified sourcing and enhanced regional supplier relationships to manage tariff-induced volatility. Providers responded with validated equivalency testing, revised terms, and increased focus on compliance. This shift supported operational continuity, protected quality standards, and rebalanced contractual risk distribution across client and provider organizations.

Methodology & Data Sources

This analysis uses a mixed-methods approach, integrating structured interviews with sponsors, service providers, and regulatory experts, as well as expert panel validations. Secondary data draw from peer-reviewed literature, official industry disclosures, regulatory guidance, and public audit reports. Analytical rigor is maintained through cross-segmentation and data triangulation, ensuring objective and accurate insights.

Why This Report Matters

  • Delivers actionable intelligence for enhancing supply chain resilience and optimizing technology investments within the pharmaceutical analytical testing outsourcing sector.
  • Equips procurement, quality, and R&D leaders to benchmark supplier selection, contracting, and risk management strategies across shifting regional and regulatory environments.
  • Supports informed planning by clarifying best practices for method validation, technology platform adoption, and transparent supplier governance in a complex landscape.

Conclusion

Strategic outsourcing in pharmaceutical analytical testing is now a foundational lever for managing scientific complexity and expediting commercialization. Organizations that prioritize robust supplier governance, technological adaptability, and capability mapping are best positioned for regulatory confidence and sustained competitive advantage.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Pharmaceutical Analytical Testing Outsourcing Market, by Service Type
8.1. Bioanalytical Testing
8.2. Impurity Testing
8.3. Microbiological Testing
8.4. Stability Testing
9. Pharmaceutical Analytical Testing Outsourcing Market, by Technology
9.1. Cell Based Assays
9.2. Chromatography
9.2.1. GC
9.2.2. HPLC
9.2.2.1. Ion Exchange
9.2.2.2. Reverse Phase
9.2.3. UHPLC
9.3. Mass Spectrometry
9.3.1. GC MS
9.3.2. LC MS MS
9.3.3. MALDI TOF
9.4. qPCR
9.5. Spectroscopy
9.5.1. FTIR
9.5.2. NMR
9.5.3. UV Vis
10. Pharmaceutical Analytical Testing Outsourcing Market, by Molecule Type
10.1. Biologic
10.2. Small Molecule
11. Pharmaceutical Analytical Testing Outsourcing Market, by Project Duration
11.1. Long Term Projects
11.2. Short Term Projects
12. Pharmaceutical Analytical Testing Outsourcing Market, by Application
12.1. Biosimilarity Assessment
12.2. Drug Discovery & Development
12.3. Quality Control
13. Pharmaceutical Analytical Testing Outsourcing Market, by End User
13.1. Academic & Government Institutes
13.2. Biotechnology Companies
13.3. Contract Research Organizations
13.4. Pharmaceutical Companies
14. Pharmaceutical Analytical Testing Outsourcing Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Pharmaceutical Analytical Testing Outsourcing Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Pharmaceutical Analytical Testing Outsourcing Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Pharmaceutical Analytical Testing Outsourcing Market
18. China Pharmaceutical Analytical Testing Outsourcing Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Absorption Systems LLC
19.6. Almac Group
19.7. Aptuit, LLC
19.8. BioAgilytix Labs
19.9. Charles River Laboratories International, Inc.
19.10. Covance Inc.
19.11. Eurofins Scientific SE
19.12. Frontage Laboratories, Inc.
19.13. Intertek Group plc
19.14. IQVIA Holdings Inc.
19.15. LGC Limited
19.16. Medpace Holdings, Inc.
19.17. Parexel International Corporation
19.18. PRA Health Sciences, Inc.
19.19. SGS S.A.
19.20. Syneos Health, Inc.
19.21. Thermo Fisher Scientific Inc.
19.22. WuXi AppTec Co., Ltd.
List of Figures
FIGURE 1. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPURITY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPURITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPURITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CELL BASED ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CELL BASED ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CELL BASED ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GC, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ION EXCHANGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ION EXCHANGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ION EXCHANGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REVERSE PHASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REVERSE PHASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REVERSE PHASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY UHPLC, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY UHPLC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY UHPLC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GC MS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GC MS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GC MS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY LC MS MS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY LC MS MS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY LC MS MS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MALDI TOF, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MALDI TOF, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MALDI TOF, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY QPCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY QPCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY QPCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY FTIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY FTIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY FTIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY NMR, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY NMR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY NMR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY UV VIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY UV VIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY UV VIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOLOGIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOLOGIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOLOGIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SMALL MOLECULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SMALL MOLECULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY LONG TERM PROJECTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY LONG TERM PROJECTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY LONG TERM PROJECTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SHORT TERM PROJECTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SHORT TERM PROJECTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SHORT TERM PROJECTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOSIMILARITY ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOSIMILARITY ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOSIMILARITY ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACADEMIC & GOVERNMENT INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. EUROPE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. EUROPE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 152. EUROPE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 153. EUROPE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 154. EUROPE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2032 (USD MILLION)
TABLE 155. EUROPE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 156. EUROPE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
TABLE 157. EUROPE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 158. EUROPE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2032 (USD MILLION)
TABLE 159. EUROPE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. EUROPE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 172. AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 174. AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 175. AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 176. AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2032 (USD MILLION)
TABLE 177. AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 178. AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
TABLE 179. AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 180. AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2032 (USD MILLION)
TABLE 181. AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 182. AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 195. ASEAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. ASEAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 197. ASEAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 198. ASEAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 199. ASEAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2032 (USD MILLION)
TABLE 200. ASEAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 201. ASEAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
TABLE 202. ASEAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 203. ASEAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2032 (USD MILLION)
TABLE 204. ASEAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 205. ASEAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 206. GCC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 207. GCC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 208. GCC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 209. GCC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 210. GCC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2032 (USD MILLION)
TABLE 211. GCC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 212. GCC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
TABLE 213. GCC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 214. GCC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2032 (USD MILLION)
TABLE 215. GCC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 216. GCC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 228. BRICS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 229. BRICS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 230. BRICS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 231. BRICS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 232. BRICS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2032 (USD MILLION)
TABLE 233. BRICS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 234. BRICS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
TABLE 235. BRICS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 236. BRICS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2032 (USD MILLION)
TABLE 237. BRICS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 238. BRICS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 239. G7 PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 240. G7 PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 241. G7 PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 242. G7 PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 243. G7 PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2032 (USD MILLION)
TABLE 244. G7 PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 245. G7 PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
TABLE 246. G7 PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 247. G7 PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2032 (USD MILLION)
TABLE 248. G7 PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 249. G7 PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 250. NATO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 251. NATO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 252. NATO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 253. NATO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 254. NATO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2032 (USD MILLION)
TABLE 255. NATO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 256. NATO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
TABLE 257. NATO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 258. NATO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2032 (USD MILLION)
TABLE 259. NATO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 260. NATO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 261. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 262. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 263. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 264. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 265. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-

Companies Mentioned

The key companies profiled in this Pharmaceutical Analytical Testing Outsourcing market report include:
  • Absorption Systems LLC
  • Almac Group
  • Aptuit, LLC
  • BioAgilytix Labs
  • Charles River Laboratories International, Inc.
  • Covance Inc.
  • Eurofins Scientific SE
  • Frontage Laboratories, Inc.
  • Intertek Group plc
  • IQVIA Holdings Inc.
  • LGC Limited
  • Medpace Holdings, Inc.
  • Parexel International Corporation
  • PRA Health Sciences, Inc.
  • SGS S.A.
  • Syneos Health, Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages199
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 11.82 Billion
Forecasted Market Value ( USD ) by 2032 $ 21.12 Billion
Compound Annual Growth Rate9.8%
Regions CoveredGlobal
No. of Companies Mentioned18

Related Topics

Related Reports

Pharmaceutical Analytical Testing Outsourcing - Global Strategic Business Report - Product Image

Pharmaceutical Analytical Testing Outsourcing - Global Strategic Business Report

  • Report
  • 112 Pages
  • Global
From
Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report by Service (Bioanalytical Testing, Stability Testing), End-use (Pharmaceutical Companies, Biopharmaceutical Companies), and Region with Growth Forecasts, 2025-2030 - Product Image

Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report by Service (Bioanalytical Testing, Stability Testing), End-use (Pharmaceutical Companies, Biopharmaceutical Companies), and Region with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Pharmaceutical Analytical Testing Services in CRO Market Size, Share & Trends Analysis Report by Service (Bioanalytical Testing, Method Development & Validation), End-use, and Region with Growth Forecasts, 2025-2030 - Product Image

Pharmaceutical Analytical Testing Services in CRO Market Size, Share & Trends Analysis Report by Service (Bioanalytical Testing, Method Development & Validation), End-use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Pharmaceutical Analytical Testing Market Report 2025 - Product Image

Pharmaceutical Analytical Testing Market Report 2025

  • Report
  • 250 Pages
  • Global
From
2025 Global Forecast for Pharmaceutical Analytical Testing Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Pharmaceutical Analytical Testing Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From

About the Pharmaceutical Analytical Testing Outsourcing Market

The Pharmaceutical Analytical Testing Outsourcing market is a subset of the Drug Discovery industry, which involves the development of new drugs and treatments. It is a highly specialized field that requires a range of analytical testing services to ensure the safety and efficacy of new drugs. Outsourcing these services to specialized companies can help reduce costs and speed up the drug development process. Analytical testing services include a range of activities such as method development and validation, stability testing, impurity profiling, and bioanalytical testing. These services are essential for ensuring the quality and safety of new drugs, and for meeting regulatory requirements. Companies in the Pharmaceutical Analytical Testing Outsourcing market include Eurofins Scientific, SGS, Intertek, Charles River Laboratories, and WuXi AppTec. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.